NCT03759808

Brief Summary

The current project will examine the effect of a brief psychological intervention on post-concussion symptoms, neurocognitive function, cerebral blood flow (CBF), and psychophysiological and salivary cortisol markers of autonomic nervous system (ANS) in a sample of 20 participants between 13-25 years of age who experience long-term post-concussive (PC) symptoms 2-9 months post-injury as well as 20 age- and sex-matched controls (non-injured) participants to provide normative data on all the above measures except for concussive symptoms.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2018

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2018

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

September 20, 2018

Completed
2 months until next milestone

First Posted

Study publicly available on registry

November 30, 2018

Completed
4.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2023

Completed
Last Updated

October 29, 2021

Status Verified

October 1, 2021

Enrollment Period

4.7 years

First QC Date

September 20, 2018

Last Update Submit

October 28, 2021

Conditions

Keywords

post-concussion syndromemild traumatic brain injuryautonomic dysfunctionconcussioncapnometry-assisted respiratory trainingcognitive behavioral therapy

Outcome Measures

Primary Outcomes (2)

  • Change in Self-Reported Symptoms After Treatment

    Severity of self-reported symptoms on the Post-Concussion Symptom Inventory

    baseline and 6 weeks

  • Change Self-Reported Quality of Life After Treatment

    Self-reported scores on quality of life on Global Quality of Life Scale

    baseline and 6 weeks

Secondary Outcomes (6)

  • Change in cerebral blood flow stress after treatment

    baseline and 6 weeks

  • Change in peak salivary cortisol after treatment

    baseline and 6 weeks

  • Change in respiration rate after treatment

    baseline and 6 weeks

  • Change in end-tidal carbon dioxide after treatment

    baseline and 6 weeks

  • Change in heart rate after treatment

    baseline and 6 weeks

  • +1 more secondary outcomes

Other Outcomes (9)

  • Change in depressive symptoms after treatment

    baseline and 6 weeks

  • Change in anxiety symptoms after treatment

    baseline and 6 weeks

  • Change in sleep quality after treatment

    baseline and 6 weeks

  • +6 more other outcomes

Study Arms (1)

Persistent Post-Concussion Symptoms

EXPERIMENTAL

Concussed participants with persistent post-concussion symptoms (PPCS) who receive the psychological intervention.

Behavioral: Psychological Intervention

Interventions

Psychological treatment protocol designed to treat anxiety and avoidance in an adolescent/young adult population. The focus of treatment will be to address cognitive and behavioral factors associated with prolonged symptoms. Cognitive factors that may be addressed include, but are not limited to, catastrophizing, black or white thinking, and false expectations. Behavior factors that may be addressed include, but are not limited to, avoidance, relaxation, and behavioral activation. The psychological intervention is also designed to help reduce psychophysiological arousal associated with anxiety and stress. Participants will also be taught controlled shallow breathing exercises designed to normalize the ratio of sympathetic/parasympathetic activity.

Persistent Post-Concussion Symptoms

Eligibility Criteria

Age13 Years - 25 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Between the ages of 13-25
  • Diagnosed with a concussion or mild traumatic brain injury by a physician
  • Currently experiencing post-concussive symptoms for at least two months after their injury but no longer than 9 months.
  • Fluent English speaker

You may not qualify if:

  • History of/or comorbid neurological conditions that might affect performance (including history of stroke, seizure disorder, moderate to severe traumatic brain injury, anoxia)
  • Severe cardiovascular conditions.
  • History of psychosis and current substance abuse or dependence.
  • Current severe symptoms of depression and/or anxiety.
  • \* No history of concussion in the past year.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of California, Los Angeles

Los Angeles, California, 90095, United States

RECRUITING

MeSH Terms

Conditions

Brain ConcussionPost-Concussion SyndromePrimary Dysautonomias

Interventions

Psychosocial Intervention

Condition Hierarchy (Ancestors)

Brain Injuries, TraumaticBrain InjuriesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesCraniocerebral TraumaTrauma, Nervous SystemHead Injuries, ClosedWounds and InjuriesWounds, NonpenetratingAutonomic Nervous System Diseases

Intervention Hierarchy (Ancestors)

PsychotherapyBehavioral Disciplines and Activities

Study Officials

  • Robert Asarnow, PhD

    University of California, Los Angeles

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Aliyah R Snyder, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: An open trial will be conducted in patients with persistent post-concussion symptoms compared to non-injured controls in order to determine whether the intervention (controlled breathing and cognitive behavioral therapy for anxiety) improves parasympathetic, HPA axis activity and cerebral blood flow, and whether improvement in parasympathetic and HPA axis activity predicts reduction in PPCS symptoms. We will compare baseline evaluations to the evaluation conducted after brief CBT and controlled breathing training to demonstrate the feasibility of normalizing parasympathetic, and HPA axis activity via this intervention. If we obtain the predicted results in the current study we will design a much larger study to identify the mechanisms of change. Healthy, non-injured control participants will provide normative data on all measures except for concussion-relevant outcomes.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Study Principal Investigator

Study Record Dates

First Submitted

September 20, 2018

First Posted

November 30, 2018

Study Start

June 1, 2018

Primary Completion

February 1, 2023

Study Completion

February 1, 2023

Last Updated

October 29, 2021

Record last verified: 2021-10

Data Sharing

IPD Sharing
Will share

All individual participant data that underlie results in a publication will be shared if requested by other researchers. These data will include Study Protocol, Statistical Analysis Plan, and Clinical Study Report. Data will be made available for sharing 6 months after publication and be available for a time frame of 2 years following initial publication. Access to IPD will be considered for researchers with a graduate degree or above for post-hoc analyses or replication efforts. Applications to access individual participant data will be reviewed by principal investigator and appointed co-investigators.

Shared Documents
STUDY PROTOCOL, SAP, ICF, CSR
Time Frame
6 months following initial publication, lasting for 2 years after initial publication.
Access Criteria
Access to individual participant data will be considered for researchers with a graduate degree or above for post-hoc analyses or replication efforts. Applications to access individual participant data will be reviewed by principal investigator and appointed co-investigators.

Locations